MOST NOTEWORTHY:

• Merriman believes GSI Technology Inc (NASDAQ: GSIT) is positioned to benefit as growing bandwidth demand and increasingly complex protocols drive the need for faster and higher density memory in networking equipment. The firm started shares with a Buy rating.
• Array Biopharma Inc (NASDAQ: ARRY) was assumed with an Outperform rating at William Blair. The firm thinks the company's pipeline contains significant value, which will be catalyzed over the next 12-18 months by continued clinical progress and potential partnerships.
• Continental Resources Inc (NYSE: CLR) was initiated with a Buy rating and $30 target at Jefferies, and points to the company's double-digit growth and strong reserve growth potential.

• Lehman initiated Ventas Inc (NYSE: VTR) with an Equal Weight rating $46 target and HCP Inc (NYSE: HCP) with an Overweight rating.
• The Boston Beer Company Inc (NYSE: SAM) was assumed with an Overweight rating and $43 target at HSBC.

Analyst initiations: GSIT, ARRY and CLR originally appeared on BloggingStocks on Thu, 07 Feb 2008 10:18:00 EST. Please see our terms for use of feeds.